Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Mol Sci ; 24(12)2023 Jun 16.
Article in English | MEDLINE | ID: mdl-37373353

ABSTRACT

Type 1 conventional dendritic cells (cDC1s) are leukocytes competent to coordinate antiviral immunity, and thus, the intracellular mechanisms controlling cDC1 function are a matter of intense research. The unfolded protein response (UPR) sensor IRE1 and its associated transcription factor XBP1s control relevant functional aspects in cDC1s including antigen cross-presentation and survival. However, most studies connecting IRE1 and cDC1 function are undertaken in vivo. Thus, the aim of this work is to elucidate whether IRE1 RNase activity can also be modeled in cDC1s differentiated in vitro and reveal the functional consequences of such activation in cells stimulated with viral components. Our data show that cultures of optimally differentiated cDC1s recapitulate several features of IRE1 activation noticed in in vivo counterparts and identify the viral analog Poly(I:C) as a potent UPR inducer in the lineage. In vitro differentiated cDC1s display constitutive IRE1 RNase activity and hyperactivate IRE1 RNase upon genetic deletion of XBP1s, which regulates production of the proinflammatory cytokines IL-12p40, TNF-α and IL-6, Ifna and Ifnb upon Poly(I:C) stimulation. Our results show that a strict regulation of the IRE1/XBP1s axis regulates cDC1 activation to viral agonists, expanding the scope of this UPR branch in potential DC-based therapies.


Subject(s)
Protein Serine-Threonine Kinases , Unfolded Protein Response , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Gene Expression Regulation , Transcription Factors/metabolism , Ribonucleases/metabolism
2.
Cells ; 8(12)2019 12 04.
Article in English | MEDLINE | ID: mdl-31817075

ABSTRACT

The unfolded protein response (UPR) is an adaptive response that maintains the fidelity of the cellular proteome in conditions that subvert the folding capacity of the cell, such as those noticed in infection and inflammatory contexts. In immunity, the UPR sensor IRE1 (Inositol-requiring enzyme 1-alpha) has emerged as a critical regulator of the homeostasis of antigen presenting cells (APCs). In the past few years, it has become clear that IRE1 plays canonical and non-canonical roles in APCs, many of which intersect with key features of these cells, including the initiation of inflammation, antibody production, and antigen presentation. The aims of the present review are to provide recent insights on the mechanisms by which IRE1 regulates the diversity of APC functions and to highlight its relevance in the coordination of innate and adaptive immunity.


Subject(s)
Antigen Presentation , Antigen-Presenting Cells/metabolism , Endoribonucleases/metabolism , Protein Serine-Threonine Kinases/metabolism , Unfolded Protein Response , Animals , Antigen-Presenting Cells/immunology , Homeostasis , Humans
3.
Front Immunol ; 9: 3050, 2018.
Article in English | MEDLINE | ID: mdl-30687308

ABSTRACT

The IRE1α/XBP1s signaling pathway is an arm of the unfolded protein response (UPR) that safeguards the fidelity of the cellular proteome during endoplasmic reticulum (ER) stress, and that has also emerged as a key regulator of dendritic cell (DC) homeostasis. However, in the context of DC activation, the regulation of the IRE1α/XBP1s axis is not fully understood. In this work, we report that cell lysates generated from melanoma cell lines markedly induce XBP1s and certain members of the UPR such as the chaperone BiP in bone marrow derived DCs (BMDCs). Activation of IRE1α endonuclease upon innate recognition of melanoma cell lysates was required for amplification of proinflammatory cytokine production and was necessary for efficient cross-presentation of melanoma-associated antigens without modulating the MHC-II antigen presentation machinery. Altogether, this work provides evidence indicating that ex-vivo activation of the IRE1α/XBP1 pathway in BMDCs enhances CD8+ T cell specific responses against tumor antigens.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Endoribonucleases/metabolism , Melanoma/immunology , Protein Serine-Threonine Kinases/metabolism , Signal Transduction/immunology , Animals , CD8-Positive T-Lymphocytes/metabolism , Cell Line, Tumor , Cross-Priming/drug effects , Cytokines/immunology , Cytokines/metabolism , Dendritic Cells/drug effects , Dendritic Cells/immunology , Dendritic Cells/metabolism , Endoplasmic Reticulum Stress/immunology , Endoribonucleases/antagonists & inhibitors , Endoribonucleases/genetics , Endoribonucleases/immunology , Humans , Hymecromone/analogs & derivatives , Hymecromone/pharmacology , Lymphocyte Activation/drug effects , Melanoma/pathology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Primary Cell Culture , Protein Serine-Threonine Kinases/antagonists & inhibitors , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/immunology , Signal Transduction/drug effects , Unfolded Protein Response/immunology , X-Box Binding Protein 1/immunology , X-Box Binding Protein 1/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...